The link between narcolepsy and cardiovascular disease (CVD) was strengthened by new evidence that the relationship applied to subclinical disease and was apparent early in life, based on a ...

The study reviewed US medical claims databases from 2005 to 2021 and compared CVD outcomes in narcolepsy patients and ...

本综述深入探讨了发作性睡病（Narcolepsy）的临床表现、治疗策略及未来方向，强调需超越经典五联征进行综合管理。 发作性睡病（Narcolepsy）是一种罕见的慢性神经学疾病，其特征性症状包括白天过度嗜睡（Excessive Daytime Sleepiness, EDS）、猝倒（Cataplexy）、夜间 ...

AXS-12, known as reboxetine back when it was available as an antidepressant in the United States, may decrease cataplexy ...

From baseline, patients treated with AXS-12 had an 83% reduction in cataplexy attacks at the end of 5 weeks compared with a 66% reduction with placebo (rate ratio [RR] 0.49, P=0.0 ...

USA: A retrospective cohort study using Medicare and commercial insurance data has found that narcolepsy is associated with ...

Jazz Pharmaceuticals said on Tuesday that it had agreed to a settlement of $145 million to resolve a series of antitrust lawsuits related to its narcolepsy drug, Xyrem.

Some common narcolepsy comorbidities include obstructive sleep apnea (OSA), attention deficit hyperactivity disorder (ADHD), restless legs syndrome (RLS), anxiety, and depression. Comorbidities ...

Narcolepsy is a nervous system disorder that involves your brain. You struggle to manage sleep patterns and stay awake. No matter how much rest you got the night before, an intense urge to sleep ...

Those who care about making America healthy need to be careful not to tie themselves so tightly to a man who never cared about actual science.

Ahead of a planned trial next month, Jazz Pharmaceuticals is moving to resolve antitrust allegations surrounding its key narcolepsy drug Xyrem with a cool $145 million settlement. | The company ...